Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California. Show more

Location: 919 East Hillsdale Boulevard, Suite 250, Foster City, CA, 94404, United States | Website: https://www.geron.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

840.7M

52 Wk Range

$1.17 - $5.06

Previous Close

$1.38

Open

$1.33

Volume

7,561,000

Day Range

$1.30 - $1.38

Enterprise Value

623M

Cash

396.9M

Avg Qtr Burn

-51.09M

Insider Ownership

0.09%

Institutional Own.

81.22%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.